1 Min Read
May 14 (Reuters) - Emblem Corp:
* EMBLEM AND CANNTAB THERAPEUTICS ANNOUNCE HEALTH CANADA APPROVAL FOR RESEARCH AND DEVELOPMENT OF CANNABINOID-BASED ORAL SUSTAINED RELEASE FORMULATION Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.